Donor-derived fungal infections in organ transplant recipients: Guidelines of the American society of transplantation, infectious diseases community of practice

American Journal of Transplantation

Volumn 12, Issue 9, 2012, Pages 2414-2428

  Singh, N ^a   Huprikar, S ^b   Burdette, S D ^c   Morris, M I ^d   Blair, J E ^e   Wheat, L J ^f  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WRIGHT STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e MAYO CLINIC   (United States)

^f MIRAVISTA DIAGNOSTICS   (United States)

Author keywords

Candida; coccidioidomycosis; cryptococcosis; donor transmission; fungal infections; histoplasmosis; transplant

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; CANDIDIASIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; DRUG DOSE REDUCTION; GRAFT RECIPIENT; HISTOPLASMOSIS; HUMAN; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MEDICAL SOCIETY; MUCORMYCOSIS; MYCOSIS; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; HUMANS; MYCOSES; ORGAN TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC; TISSUE DONORS; UNITED STATES;

EID: 84865609793     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04100.x     Document Type: Article

References (120)

1. Ison MG, Hager J, Blumberg E, et al,. Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9: 1929-1935.
2. Albano L, Bretagne S, Mamzer-Bruneel MF, et al,. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: A multicenter study in France. Clin Infect Dis 2009; 48: 194-202.
3. Baddley JW, Andes DR, Marr KA, et al,. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010; 50: 1559-1567.
4. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979; 121: 1193-1254.
5. Garzoni C, Ison MG,. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation. Transplantation 2011; 92: 1297-1300.
6. Organ Procurement and Transplantation Network 2010. Post-Transplant reporting of potential transmission of disease or medical conditions, including malignancies. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/ policies/pdfs/policy-16.pdf. Accessed November 8, 2011.
7. Matignon M, Botterel F, Audard V, et al,. Outcome of renal transplantation in eight patients with Candida sp. contamination of preservation fluid. Am J Transplant 2008; 8: 697-700. (Pubitemid 351287544)
8. Canaud G, Timsit MO, Zuber J, et al,. Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy. Nephrol Dial Transplant 2009; 24: 1325-1327.
9. Mai H, Champion L, Ouali N, et al,. Candida albicans arteritis transmitted by conservative liquid after renal transplantation: A report of four cases and review of the literature. Transplantation 2006; 82: 1163-1167. (Pubitemid 44748018)
10. Spees EK, Light JA, Oakes DD, Reinmuth B,. Experiences with cadaver renal allograft contamination before transplantation. Br J Surg 1982; 69: 482-485. (Pubitemid 12038329)
11. Veroux M, Corona D, Giuffrida G, et al,. Acute renal failure due to ureteral obstruction in a kidney transplant recipient with Candida albicans contamination of preservation fluid. Transpl Infect Dis 2009; 11: 266-268.
12. Anderson CB, Haid SD, Hruska KA, Etheredge EA,. Significance of microbial contamination of stored cadaver kidneys. Arch Surg 1978; 113: 269-271. (Pubitemid 8308265)
13. Veroux M, Corona D, Scriffignano V, et al,. Contamination of preservation fluid in kidney transplantation: Single-center analysis. Transplant Proc 2010; 42: 1043-1045.
14. Akhtar MZ, Roos J, Middleton R, et al,. Yeast perfusion fluid contamination in pancreas transplantation. J Hosp Infect 2011; 78: 68-69.
15. Laouad I, Buchler M, Noel C, et al,. Renal artery aneurysm secondary to Candida albicans in four kidney allograft recipients. Transplant Proc 2005; 37: 2834-2836. (Pubitemid 41354749)
16. Fisher JF, Sobel JD, Kauffman CA, Newman CA,. Candida urinary tract infections-treatment. Clin Infect Dis 2011; 52 (Suppl 6): S457-S466.
17. Pfaller MA, Diekema DJ, Sheehan DJ,. Interpretive breakpoints for fluconazole and Candida revisited: A blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 2006; 19: 435-447.
18. Pappas PG, Kauffman CA, Andes D, et al,. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-535.
19. Thomas LD, Miller GG,. Interactions between antiinfective agents and immunosuppressants. Am J Transplant 2009; 9 (Suppl 4): S263-S266.
20. Gubbins PO, Anaissie EJ,. Antifungal Therapy. In:, Anaissie EJ, McGinnis MR, Pfaller MA, eds. Clinical Mycology: Elselvier, 2009: 161-197.
21. Fisher JF, Woeltje K, Espinel-Ingroff A, Stanfield J, DiPiro JT,. Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: Further favorable experience. Clin Microbiol Infect 2003; 9: 1024-1027. (Pubitemid 37361832)
22. Cerutti E, Stratta C, Romagnoli R, et al,. Bacterial- and fungal-positive cultures in organ donors: Clinical impact in liver transplantation. Liver Transpl 2006; 12: 1253-1259. (Pubitemid 44194594)
23. Agustin J, Lacson S, Raffalli J, Aguero-Rosenfeld ME, Wormser GP,. Failure of a lipid amphotericin B preparation to eradicate candiduria: Preliminary findings based on three cases. Clin Infect Dis 1999; 29: 686-687. (Pubitemid 29439977)
24. van Etten EW, van den Heuvel-de Groot C, Bakker-Woudenberg IA,. Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. J Antimicrob Chemother 1993; 32: 723-739. (Pubitemid 23343756)
25. Hanaway MJ, Woodle ES, Mulgaonkar S, et al,. Alemtuzumab induction in renal transplantation. N Engl J Med 2011; 364: 1909-1919.
26. Janny S, Bert F, Dondero F, et al,. Microbiological findings of culture-positive preservation fluid in liver transplantation. Transpl Infect Dis 2011; 13: 9-14.
27. Audet M, Piardi T, Panaro F, et al,. Incidence and clinical significance of bacterial and fungal contamination of the preservation solution in liver transplantation. Transpl Infect Dis 2011; 13: 84-88.
28. Potter van Loon BJ, Lichtendahl AT, Mulder SS, Van Houten H, Gooszen HG, Van den Broek PJ,. Microbial contamination of donor duodenum in whole-pancreas transplantation. Diabetes 1989; 38 (suppl 1): 242-243.
29. Ciancio G, Burke GW, Viciana AL, et al,. Destructive allograft fungal arteritis following simultaneous pancreas-kidney transplantation. Transplantation 1996; 61: 1172-1175.
30. Brooks RG, Hofflin JM, Jamieson SW, Stinson EB, Remington JS,. Infectious complications in heart-lung transplant recipients. Am J Med 1985; 79: 412-422. (Pubitemid 16253667)
31. Dummer JS, Lazariashvilli N, Barnes J, Ninan M, Milstone AP,. A survey of antifungal management in lung transplantation. J Heart Lung Transplant 2004; 12: 1376-1381. (Pubitemid 40018160)
32. Hadjiliadis DH, Howell DN, Davis RD, et al,. Anastomotic infections in lung transplant recipients. Ann Transplant 2000; 3: 13-19.
33. Mossad SB, Avery RK, Goormastic M, Hobbs RE, Stewart RW,. Significance of positive cultures from donor left atrium and postpreservation fluid in heart transplantation. Transplantation 1997; 64: 1209-1210. (Pubitemid 27467953)
34. Sun HY, Wagener MM, Singh N,. Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: Evidence-based evolving trends. Clin Infect Dis 2009; 48: 1566-1576.
35. Garcia-Hermoso D, Janbon G, Dromer F,. Epidemiological evidence for dormant cryptococcus neoformans infection. J Clin Microbiol 1999; 37: 3204-3209. (Pubitemid 29455206)
36. Saha DC, Goldman DL, Shao X, et al,. Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol 2007; 14: 1550-1554.
37. Kapoor A, Flenchner SM, O'Malley K, Paolone D, File TM, Jr,., Cutrona AF,. Cryptococcal meningitis in renal transplant patients associated with environmental exposure. Transpl Infect Dis 1999; 1: 213-217.
38. Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O,. Primary cutaneous cryptococcosis: A distinct clinical entity. Clin Infect Dis 2003; 36: 337-347. (Pubitemid 36169670)
39. Nosanchuk JD, Shoham S, Fries BC, Shapiro DS, Levitz SM, Casadevall A,. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med 2000; 132: 205-208. (Pubitemid 30064920)
40. Baddley JW, Schain DC, Gupte AA, et al,. Transmission of Cryptococcus neoformans by Organ Transplantation. Clin Infect Dis 2011; 52: e94-e98.
41. Kanj SS, Welty-Wolf K, Madden J, et al,. Fungal infections in lung and heart-lung transplant recipients: Report of 9 cases and review of the literature. Medicine 1996; 75: 142-156. (Pubitemid 26159211)
42. Sun HY, Alexander BD, Lortholary O, et al,. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis 2010; 51: 1062-1069.
43. Lyon M, Kaul D, Ehsan A, et al,. Infectious disease transmission from organ donors with meningitis or encephalitis. In American Transplant Congress. Philadelphia PA, 2011.
44. Matsumoto M, Kita Y, Gocho T, et al,. Successful liver transplantation from a living donor with asymptomatic pulmonary cryptococcosis. Liver Transpl 2011; 17: 351-353.
45. MacDougall L, Kidd SE, Galanis E, et al,. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 2007; 13: 42-50. (Pubitemid 46057836)
46. Datta K, Bartlett KH, Baer R, et al,. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 2009; 15: 1185-1191.
47. Byrnes EJ, 3rd, Bartlett KH, Perfect JR, Heitman J,. Cryptococcus gattii: An emerging fungal pathogen infecting humans and animals. Microbes Infect 2011; 13: 895-907.
48. Pappas PG, Perfect JR, Cloud GA, et al,. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33: 690-699. (Pubitemid 32762943)
49. Ison MG, Nalesnik MA,. An update on donor-derived disease transmission in organ transplantation. Am J Transplant 2011; 11: 1123-1130.
50. Singh N, Alexander BD, Lortholary O, et al,. Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality. J Infect Dis 2007; 195: 756-764.
51. Dromer F, Mathoulin-Plissier S, Launay O, Lortholary O, French Cryptococcis Study G. Determinants of disease presentation and outcome during cryptococcosis: The CryptoA/D study. PloS Med 2007; 4: e21.
52. Jarvis JN, Harrison TS,. Pulmonary cryptococcosis. Semin Respir Crit Care Med 2008; 29: 141-150. (Pubitemid 351438992)
53. Singh N, Alexander BD, Lortholary O, et al,. Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen. Clin Infect Dis 2008; 46: e12-e18. (Pubitemid 351269182)
54. Mueller NJ, Fishman JA,. Asymptomatic pulmonary cryptococcosis in solid organ transplantation: Report of four cases and review of the literature. Transp Infect Dis 2003; 5: 140-143. (Pubitemid 37356357)
55. Singh N, Forrest G,. Cryptococcosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S192-S198.
56. Perfect JR, Dismukes WE, Dromer F, et al,. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010; 50: 291-322.
57. Singh N, Lortholary O, Alexander BD, et al,. An "immune reconstitution syndrome"-like entity associated with Cryptococcus neoformans infections in organ transplant recipients. Clin Infect Dis 2005; 40: 1756-1761. (Pubitemid 40799944)
58. Kontoyiannis DP, Lewis RE, Alexander BD, et al,. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother 2008; 52: 735-738. (Pubitemid 351170854)
59. Silveira EP, Husain S, Kwak EJ, et al,. Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab. Transpl Infect Dis 2007; 9: 22-27.
60. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE,. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99 (Suppl): 1-132.
61. Davies SF, Sarosi GA, Peterson PK,. Disseminated histoplasmosis in renal transplant recipients. Am J Surg 1979; 137: 686-691. (Pubitemid 9179090)
62. Wheat LJ, Smith EJ, Sathapatayavongs B, et al,. Histoplasmosis in renal alograft recipients. Two large urban outbreaks. Arch Intern Med 1983; 143: 703-707. (Pubitemid 13161837)
63. Peddi VR, Hariharan S, First MR,. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996; 10: 160-165. (Pubitemid 26091825)
64. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC,. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7: 109-115. (Pubitemid 43015445)
65. Cuellar-Rodriguez J, Avery RK, Lard M, et al,. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49: 710-716.
66. Pappas PG, Alexander BD, Andes DR, et al,. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101-1111.
67. Grim SA, Proia L, Miller R, et al,. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis 2012, 14: 17-23.
68. Wheat J, French ML, Kohler RB, et al,. The diagnostic laboratory tests for histoplasmosis: Analysis of experience in a large urban outbreak. Ann Intern Med 1982; 97: 680-685. (Pubitemid 13251637)
69. Wheat LJ, Freifeld AG, Kleiman MB, et al,. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 807-825. (Pubitemid 47580372)
70. Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ,. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007; 14: 1587-1591.
71. Wheat LJ,. Histoplasmosis in Indianapolis. Clin Infect Dis 1992; 14 (Suppl 1): S91-S99.
72. Hage CA, Ribes JA, Wengenack NL, et al,. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53: 448-454.
73. Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M,. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002; 4: 148-151. (Pubitemid 35364779)
74. Restrepo A, Tobon A, Clark B, et al,. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007; 54: 319-327. (Pubitemid 46395016)
75. Sunenshine RH, Anderson S, Erhart L, et al,. Public health surveillance for coccidioidomycosis in Arizona. Ann N Y Acad Sci 2007; 1111: 96-102. (Pubitemid 47573039)
76. Cox RA, Magee DM,. Coccidioidomycosis: Host response and vaccine development. Clinical microbiology reviews 2004; 17: 804-839. (Pubitemid 39372519)
77. Fisher MC, Koenig GL, White TJ, Taylor JW,. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002; 94: 73-84. (Pubitemid 34776081)
78. Einstein HE, Johnson RH,. Coccidioidomycosis: New aspects of epidemiology and therapy. Clin Infect Dis 1993; 16: 349-354.
79. Pappagianis D,. Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988; 2: 199-238.
80. Ampel NM,. The complex immunology of human coccidioidomycosis. Ann N Y Acad Sci 2007; 1111: 245-258. (Pubitemid 47573029)
81. Blair JE, Logan JL,. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001; 33: 1536-1544. (Pubitemid 34246148)
82. Vucicevic D, Carey EJ, Blair JE,. Coccidioidomycosis in liver transplant recipients in an endemic area. Am J Transplant 2011; 11: 111-119.
83. Miller M, Hendren R, Gilligan P,. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004; 42: 2347-2349. (Pubitemid 38637883)
84. Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kape lanski DP, Jamieson SW,. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thor Surg 2002; 73: 306-308. (Pubitemid 34084592)
85. Wright PW, Pappagianis D, Wilson M, et al,. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003; 37: 1265-1269. (Pubitemid 37372519)
86. Carvalho C, Ferreira I, Gaiao S, et al,. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis 2010; 12: 151-154.
87. Brugiere O, Forget E, Biondi G, et al,. Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France. Transplantation 2009; 88: 1319-1320.
88. Engelthaler DM, Chiller T, Schupp JA, et al,. Next-generation sequencing of Coccidioides immitis isolated during cluster investigation. Emerg Infect Dis 2011; 17: 227-232.
89. Blodget E, Jan Geiseler P, Larsen RA, Stapfer M, Qazi Y, Petrovic LM,. Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients. Transpl Infect Dis 2011 [Epub ahead of print].
90. Dierberg KL, Marr KA, Subramanian A, et al,. Donor-derived organ transplant transmission of coccidioidomycosis. Transpl Infect Dis 2011 [Epub ahead of print].
91. Blair JE, Mulligan DC,. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis 2007; 9: 78-82.
92. Pappagianis D, Zimmer BL,. Serology of coccidioidomycosis. Clin Microbiol Rev 1990; 3: 247-268.
93. Blair JE,. Coccidioidomycosis in patients who have undergone transplantation. Ann N Y Acad Sci 2007; 1111: 365-376. (Pubitemid 47573013)
94. Blair J, Braddy C,. Azoles prevent reactivation of prior and clinically quiescent coccidioidomycosis in patients undergoing solid oran transplantation. In 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, 2005.
95. Keckich DW, Blair JE, Vikram HR, Seville MT, Kusne S,. Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients. Transplantation 2011; 92: 88-93.
96. Vikram HR, Dosanjh A, Blair JE,. Coccidioidomycosis and lung transplantation. Transplantation 2011; 92: 717-721.
97. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, et al,. Coccidioidomycosis. Clin Infect Dis 2005; 41: 1217-1223. (Pubitemid 41532662)
98. Kim MM, Vikram HR, Kusne S, Seville MT, Blair JE,. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis 2011; 53: 1060-1066.
99. Battaglia M, Ditonno P, Selvaggio O, et al,. Kidney transplants from infected donors: Our experience. Transplant Proc 2004; 36: 491-492. (Pubitemid 38534297)
100. Zhan HX, Lv Y, Zhang Y, et al,. Hepatic and renal artery rupture due to Aspergillus and Mucor mixed infection after combined liver and kidney transplantation: A case report. Transplant Proc 2008; 40: 1771-1773. (Pubitemid 351853223)
101. Linden E, Restrepo D, Dikman S, Murphy B, Huprikar S,. Aspergillus infection limited to renal allograft: Case report and review of literature. Transpl Infect Dis 2006; 8: 177-181. (Pubitemid 44196185)
102. Maranes A, Portoles J, Blanco J, et al,. Aspergillus infection of a renal allograft without evidence of a site of origin. Nephrol Dial Transplant 1996; 11: 1639-1642. (Pubitemid 26252740)
103. Johnston O, Little DM, Hickey D, Conlon PJ,. Aspergillus 'fungus ball' within a cadaveric renal transplant graft. Nephrol Dial Transplant 2004; 19: 1317-1318. (Pubitemid 38628161)
104. Garrido J, Lerma JL, Heras M, et al,. Pseudoaneurysm of the iliac artery secondary to Aspergillus infection in two recipients of kidney transplants from the same donor. Am J Kidney Dis 2003; 41: 488-492. (Pubitemid 36152471)
105. Shoham S, Hinestrosa F, Moore J, Jr,., O'Donnell S, Ruiz M, Light J,. Invasive filamentous fungal infections associated with renal transplant tourism. Transpl Infect Dis 2010; 12: 371-374.
106. Stas KJ, Louwagie PG, Van Damme BJ, Coosemans W, Waer M, Vanrenterghem YF,. Isolated zygomycosis in a bought living unrelated kidney transplant. Transpl Int 1996; 9: 600-602. (Pubitemid 26355915)
107. Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF,. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest 1996; 109: 1119-1124. (Pubitemid 26113667)
108. Mueller NJ, Weisser M, Fehr T, et al,. Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor. Transpl Infect Dis 2010; 12: 54-59.
109. Rammaert B, Lanternier F, Zahar JR, et al,. Healthcare-associated mucormycosis. Clin Infect Dis 2012; 54 (Suppl 1): S44-S54.
110. van der Vliet JA, Tidow G, Kootstra G, et al,. Transplantation of contaminated organs. Br J Surg 1980; 67: 596-598. (Pubitemid 10056814)
111. Alexander BD, Schell WA, Siston AM, et al,. Fatal Apophysomyces elegans infection transmitted by deceased donor renal allografts. Am J Transplant 2010; 10: 2161-2167.
112. Wieden MA, Lundergan LL, Blum J, et al,. Detection of coccidioidal antibodies by 33-kDa spherule antigen, Coccidioides EIA, and standard serologic tests in sera from patients evaluated for coccidioidomycosis. J Infect Dis 1996; 173: 1273-1277. (Pubitemid 26251476)
113. Blair JE, Coakley B, Santelli AC, Hentz JG, Wengenack NL,. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia 2006; 162: 317-324. (Pubitemid 44819314)
114. Durkin M, Connolly P, Kuberski T, et al,. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis 2008; 47: e69-e73.
115. Durkin M, Estok L, Hospenthal D, et al,. Detection of Coccidioides antigenemia following dissociation of immune complexes. Clin Vaccine Immunol 2009; 16: 1453-1456.
116. Reed C, Ibrahim A, Edwards JE, Jr,., Walot I, Spellberg B,. Deferasirox, an iron-chelating agent, a salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemotherap 2008; 50: 3968-3969. (Pubitemid 44684931)
117. Bhat SV, Paterson DL, Rinaldi MG, Veldkamp PJ,. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 2007; 39: 87-90. (Pubitemid 46277156)
118. Walsh TJ, Anaissie EJ, Denning DW, et al,. Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America. CID 2008; 46: 327-360. (Pubitemid 351265310)
119. Revankar S,. Filamentous Fungi Other than Aspergillus and Zygomycetes in Organ Transplant Recipients. In Antimicrobeorg. ESun Technologies. Pittsburgh, PA. 2011.
120. Kubak BM, Huprikar SS,. Emerging & rare fungal infections in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S208-S226.